178 related articles for article (PubMed ID: 36385095)
1. RasGRP1 promotes the acute inflammatory response and restricts inflammation-associated cancer cell growth.
Wang C; Li X; Xue B; Yu C; Wang L; Deng R; Liu H; Chen Z; Zhang Y; Fan S; Zuo C; Sun H; Zhu H; Wang J; Tang S
Nat Commun; 2022 Nov; 13(1):7001. PubMed ID: 36385095
[TBL] [Abstract][Full Text] [Related]
2. RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.
Depeille P; Henricks LM; van de Ven RA; Lemmens E; Wang CY; Matli M; Werb Z; Haigis KM; Donner D; Warren R; Roose JP
Nat Cell Biol; 2015 Jun; 17(6):804-15. PubMed ID: 26005835
[TBL] [Abstract][Full Text] [Related]
3. Targeted deletion of RasGRP1 impairs skin tumorigenesis.
Sharma A; Fonseca LL; Rajani C; Yanagida JK; Endo Y; Cline JM; Stone JC; Ji J; Ramos JW; Lorenzo PS
Carcinogenesis; 2014 May; 35(5):1084-91. PubMed ID: 24464785
[TBL] [Abstract][Full Text] [Related]
4. Sp1-regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.
Zhang X; Zhuang H; Han F; Shao X; Liu Y; Ma X; Wang Z; Qiang Z; Li Y
Liver Int; 2018 Nov; 38(11):2006-2017. PubMed ID: 29655291
[TBL] [Abstract][Full Text] [Related]
5. RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
Gbenedio OM; Bonnans C; Grun D; Wang CY; Hatch AJ; Mahoney MR; Barras D; Matli M; Miao Y; Garcia KC; Tejpar S; Delorenzi M; Venook AP; Nixon AB; Warren RS; Roose JP; Depeille P
JCI Insight; 2019 Jun; 5(15):. PubMed ID: 31237864
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1.
de la Luz Sierra M; Sakakibara S; Gasperini P; Salvucci O; Jiang K; McCormick PJ; Segarra M; Stone J; Maric D; Zhu J; Qian X; Lowy DR; Tosato G
Blood; 2010 May; 115(19):3970-9. PubMed ID: 20203268
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin.
Oki-Idouchi CE; Lorenzo PS
Cancer Res; 2007 Jan; 67(1):276-80. PubMed ID: 17210708
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity.
Baars MJD; Douma T; Simeonov DR; Myers DR; Kulhanek K; Banerjee S; Zwakenberg S; Baltissen MP; Amini M; de Roock S; van Wijk F; Vermeulen M; Marson A; Roose JP; Vercoulen Y
Eur J Immunol; 2021 Feb; 51(2):471-482. PubMed ID: 33065764
[TBL] [Abstract][Full Text] [Related]
9. A Focused Review of Ras Guanine Nucleotide-Releasing Protein 1 in Immune Cells and Cancer.
Hsu TC; Rodrigues GOL; Winer H; Hixon JA; Li W; Tarasova NI; Durum SK
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675167
[TBL] [Abstract][Full Text] [Related]
10. Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
Karra L; Romero-Moya D; Ksionda O; Krush M; Gu Z; Mues M; Depeille P; Mullighan C; Roose JP
Oncogene; 2020 Nov; 39(45):6920-6934. PubMed ID: 32989257
[TBL] [Abstract][Full Text] [Related]
11. Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.
Wen Z; Yun G; Hebert A; Kong G; Ranheim EA; Finn R; Rajagoplan A; Li S; Zhou Y; Yu M; Damnernsawad A; Roose JP; Coon JJ; Wen R; Wang D; Zhang J
Blood; 2021 Jun; 137(23):3259-3271. PubMed ID: 33512434
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.
Hartzell C; Ksionda O; Lemmens E; Coakley K; Yang M; Dail M; Harvey RC; Govern C; Bakker J; Lenstra TL; Ammon K; Boeter A; Winter SS; Loh M; Shannon K; Chakraborty AK; Wabl M; Roose JP
Sci Signal; 2013 Mar; 6(268):ra21. PubMed ID: 23532335
[TBL] [Abstract][Full Text] [Related]
13. RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.
Luke CT; Oki-Idouchi CE; Cline JM; Lorenzo PS
Cancer Res; 2007 Nov; 67(21):10190-7. PubMed ID: 17974959
[TBL] [Abstract][Full Text] [Related]
14. TGF-β suppresses RasGRP1 expression and supports regulatory T cell resistance against p53-induced CD28-dependent T-cell apoptosis.
Takami M; Cunha C; Motohashi S; Nakayama T; Iwashima M
Eur J Immunol; 2018 Dec; 48(12):1938-1943. PubMed ID: 30298904
[TBL] [Abstract][Full Text] [Related]
15. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells.
Roose JP; Mollenauer M; Gupta VA; Stone J; Weiss A
Mol Cell Biol; 2005 Jun; 25(11):4426-41. PubMed ID: 15899849
[TBL] [Abstract][Full Text] [Related]
16. RasGRP1 and RasGRP3 Are Required for Efficient Generation of Early Thymic Progenitors.
Golec DP; Henao Caviedes LM; Baldwin TA
J Immunol; 2016 Sep; 197(5):1743-53. PubMed ID: 27465532
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.
Klinger MB; Guilbault B; Goulding RE; Kay RJ
Oncogene; 2005 Apr; 24(16):2695-704. PubMed ID: 15829980
[TBL] [Abstract][Full Text] [Related]
18. RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.
Xu J; Liu M; Yu M; Shen J; Zhou J; Hu J; Zhou Y; Zhang W
IUBMB Life; 2019 Sep; 71(9):1391-1400. PubMed ID: 31120617
[TBL] [Abstract][Full Text] [Related]
19. Differential requirement of RasGRP1 for γδ T cell development and activation.
Chen Y; Ci X; Gorentla B; Sullivan SA; Stone JC; Zhang W; Pereira P; Lu J; Zhong XP
J Immunol; 2012 Jul; 189(1):61-71. PubMed ID: 22623331
[TBL] [Abstract][Full Text] [Related]
20. Defective expression of Ras guanyl nucleotide-releasing protein 1 in a subset of patients with systemic lupus erythematosus.
Yasuda S; Stevens RL; Terada T; Takeda M; Hashimoto T; Fukae J; Horita T; Kataoka H; Atsumi T; Koike T
J Immunol; 2007 Oct; 179(7):4890-900. PubMed ID: 17878389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
